Advanced BioMedical Technologies, Inc.
ABMT
$0.0002
-$0.0004-66.67%
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 200.00 | 100.00 | 47.20K | 62.30K | 1.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.00 | 100.00 | 47.20K | 62.30K | 1.00K |
| Cost of Revenue | 0.00 | 0.00 | 10.10K | 18.00K | 800.00 |
| Gross Profit | 100.00 | 100.00 | 37.10K | 44.40K | 100.00 |
| SG&A Expenses | 50.70K | 44.20K | 43.20K | 97.40K | 59.20K |
| Depreciation & Amortization | 6.60K | 12.40K | 15.70K | 15.10K | 14.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 112.00K | 113.20K | 135.90K | 172.50K | 117.40K |
| Operating Income | -111.80K | -113.20K | -88.60K | -110.20K | -116.40K |
| Income Before Tax | -198.70K | -189.10K | -172.00K | -193.30K | -205.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -198.70K | -189.10K | -172.00K | -193.30K | -205.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -198.70K | -189.10K | -172.00K | -193.30K | -205.20K |
| EBIT | -111.80K | -113.20K | -88.60K | -110.20K | -116.40K |
| EBITDA | -108.60K | -109.60K | -84.50K | -106.20K | -112.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 70.22M | 70.22M | 70.22M | 69.99M | 69.97M |
| Average Diluted Shares Outstanding | 70.46M | 70.46M | 70.30M | 69.99M | 70.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
